Free Daily Biotech Industry Newsletter
Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 150,000 biotech professionals who subscribe to FierceBiotech for FREE!
Shares of BioSante ($BPAX) shot up more than 20% this morning after the developer heralded data showing improved survival rates in an early trial of GVAX for pancreatic cancer. The data is from a trial that recruited 30 patients. Story
| Tuesday, February 10th | 1pm ET / 10am PT | Presented by: Rho
Medical Governance ensures we apply good medical science, integrity, and ethics to the discovery & development of products. Dr. Jack Modell will define the meaning and describe the principles of medical governance, discuss why it is so important, and give examples of what can go wrong without it. Reserve Your Spot Today!
FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 150,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!